My expectation of the upcoming timeline,
1. fda advises no change following type A meeting
2. Mid December Overwhelming efficacy following next interim analysis and gains approval for use from fda.
3. Msb request second type A meeting for GVHD with entirely new staff from the fda who say “silviu, broooo, so so sorry for how shit my colleagues are at doing there job, I hired them from Craigslist, this should have been approved 2 months ago, but yeah bro no dramas, consider it approved now that you also have approval for ARDS, anyway I gotta go man, got some people to sack, see you at the next one legend (chf and back pain)
4.back pain and chf results come out (hopefully positive)
- Forums
- ASX - By Stock
- Ann: Novartis and Mesoblast Remestemcel-L Collaboration
My expectation of the upcoming timeline,1. fda advises no change...
-
-
- There are more pages in this discussion • 297 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.31 |
Change
0.150(13.0%) |
Mkt cap ! $1.490B |
Open | High | Low | Value | Volume |
$1.15 | $1.33 | $1.15 | $25.26M | 19.99M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 161000 | $1.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.31 | 50400 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 161000 | 1.300 |
6 | 101986 | 1.295 |
6 | 226866 | 1.290 |
4 | 70613 | 1.285 |
5 | 137074 | 1.280 |
Price($) | Vol. | No. |
---|---|---|
1.310 | 50400 | 2 |
1.315 | 2007 | 1 |
1.320 | 40992 | 3 |
1.325 | 20772 | 3 |
1.330 | 139522 | 8 |
Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online